| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.945 | 0.003 | 0.945 | Aldehyde oxidase inhibitor | 0.417 0.045 CID_5488307 0.48 0.036 CID_15372481 | ||
| 0.922 | 0.001 | 0.922 | Cystathionine beta-synthase inhibitor | 0.899 0.001 CID_5488307 0.892 0.001 CID_15372481 | ||
| 0.9 | 0.003 | 0.9 | Caspase 9 stimulant | 0.894 0.003 CID_5488307 0.897 0.003 CID_15372481 | ||
| 0.868 | 0.004 | 0.907 | Antioxidant | 0.898 0.004 CID_5488307 0.907 0.004 CID_15372481 | CID_15372481 | |
| 0.864 | 0.004 | 0.869 | Free radical scavenger | 0.857 0.004 CID_5488307 0.869 0.003 CID_15372481 | CID_15372481 | |
| 0.843 | 0.003 | 0.961 | Histamine release inhibitor | 0.923 0.002 CID_5488307 0.961 0.002 CID_15372481 | CID_15372481 | |
| 0.841 | 0.001 | 0.841 | Creatine kinase inhibitor | 0.364 0.003 CID_5488307 0.397 0.003 CID_15372481 | ||
| 0.837 | 0.012 | 0.837 | Apoptosis agonist | 0.835 0.013 CID_5488307 0.833 0.013 CID_15372481 | ||
| 0.824 | 0.004 | 0.824 | Amyloid beta aggregation inhibitor | 0.572 0.009 CID_5488307 0.594 0.008 CID_15372481 | ||
| 0.799 | 0.002 | 0.799 | GABA C receptor rho-3 antagonist | 0.391 0.066 CID_5488307 0.418 0.054 CID_15372481 | ||
| 0.801 | 0.006 | 0.801 | 15-Lipoxygenase inhibitor | 0.228 0.184 CID_15372481 | ||
| 0.796 | 0.004 | 0.796 | 12-Lipoxygenase inhibitor | 0.204 0.147 CID_15372481 | ||
| 0.79 | 0.002 | 0.79 | Peroxidase inhibitor | 0.328 0.032 CID_5488307 0.368 0.025 CID_15372481 | ||
| 0.783 | 0.006 | 0.783 | Aryl hydrocarbon receptor agonist | 0.318 0.056 CID_5488307 0.304 0.06 CID_15372481 | ||
| 0.753 | 0.005 | 0.753 | Caspase 3 stimulant | 0.624 0.009 CID_5488307 0.614 0.009 CID_15372481 | ||
| 0.693 | 0.004 | 0.693 | Superoxide dismutase inhibitor | 0.17 0.155 CID_5488307 0.217 0.1 CID_15372481 | ||
| 0.691 | 0.003 | 0.691 | Interleukin 4 antagonist | 0.456 0.005 CID_5488307 0.459 0.005 CID_15372481 | ||
| 0.714 | 0.031 | 0.932 | Alpha-glucosidase inhibitor | 0.904 0.007 CID_5488307 0.932 0.005 CID_15372481 | CID_15372481 | |
| 0.677 | 0.006 | 0.677 | Lipoxygenase inhibitor | 0.22 0.121 CID_5488307 0.226 0.117 CID_15372481 | ||
| 0.691 | 0.021 | 0.92 | Transcription factor NF kappa B inhibitor | 0.903 0.006 CID_5488307 0.92 0.005 CID_15372481 | CID_15372481 | |
| 0.67 | 0.004 | 0.67 | Breast cancer-resistant protein inhibitor | 0.135 0.03 CID_5488307 0.14 0.028 CID_15372481 | ||
| 0.696 | 0.031 | 0.858 | Antiinflammatory | 0.857 0.009 CID_5488307 0.858 0.009 CID_15372481 | CID_15372481 | |
| 0.669 | 0.004 | 0.951 | Monophenol monooxygenase inhibitor | 0.919 0.002 CID_5488307 0.951 0.002 CID_15372481 | CID_15372481 | |
| 0.663 | 0.003 | 0.842 | Amylase inhibitor | 0.832 0.001 CID_5488307 0.842 0.001 CID_15372481 | CID_15372481 | |
| 0.66 | 0.003 | 0.91 | Xanthine oxidase inhibitor | 0.858 0.002 CID_5488307 0.91 0.002 CID_15372481 | CID_15372481 | |
| 0.655 | 0.004 | 0.655 | MAO A inhibitor | 0.089 0.072 CID_5488307 0.091 0.071 CID_15372481 | ||
| 0.649 | 0.006 | 0.719 | 5 Hydroxytryptamine release inhibitor | 0.708 0.004 CID_5488307 0.719 0.004 CID_15372481 | CID_15372481 | |
| 0.647 | 0.005 | 0.647 | MAO inhibitor | |||
| 0.632 | 0.003 | 0.64 | NADPH oxidase inhibitor | 0.575 0.004 CID_5488307 0.64 0.003 CID_15372481 | CID_15372481 | |
| 0.629 | 0.004 | 0.824 | Melanin inhibitor | 0.824 0.002 CID_5488307 0.816 0.002 CID_15372481 | CID_5488307 | |
| 0.61 | 0.002 | 0.61 | GABA C receptor rho-2 antagonist | 0.178 0.044 CID_5488307 0.187 0.037 CID_15372481 | ||
| 0.599 | 0.004 | 0.599 | NOS3 expression enhancer | 0.594 0.004 CID_5488307 0.599 0.004 CID_15372481 | ||
| 0.591 | 0.008 | 0.647 | Hypoxia-inducible factor 1 alpha inhibitor | 0.647 0.005 CID_5488307 0.619 0.007 CID_15372481 | CID_5488307 | |
| 0.578 | 0.005 | 0.578 | P-glycoprotein inhibitor | 0.42 0.014 CID_5488307 0.423 0.014 CID_15372481 | ||
| 0.571 | 0.003 | 0.571 | Carbonic anhydrase III inhibitor | 0.369 0.004 CID_5488307 0.39 0.004 CID_15372481 | ||
| 0.572 | 0.01 | 0.689 | Antiamyloidogenic | 0.673 0.005 CID_5488307 0.689 0.005 CID_15372481 | CID_15372481 | |
| 0.558 | 0.012 | 0.68 | Nitric oxide antagonist | 0.666 0.007 CID_5488307 0.68 0.006 CID_15372481 | CID_15372481 | |
| 0.55 | 0.005 | 0.55 | Topoisomerase II inhibitor | 0.538 0.005 CID_5488307 0.537 0.005 CID_15372481 | ||
| 0.55 | 0.005 | 0.55 | Pyruvate kinase inhibitor | 0.249 0.061 CID_5488307 0.252 0.06 CID_15372481 | ||
| 0.556 | 0.014 | 0.637 | Apoptosis antagonist | 0.629 0.007 CID_5488307 0.637 0.006 CID_15372481 | CID_15372481 | |
| 0.551 | 0.011 | 0.77 | Hypoglycemic | 0.77 0.004 CID_5488307 0.754 0.004 CID_15372481 | CID_5488307 | |
| 0.55 | 0.018 | 0.7 | Spasmolytic | 0.657 0.009 CID_5488307 0.7 0.006 CID_15372481 | CID_15372481 | |
| 0.533 | 0.003 | 0.9 | Beta glucuronidase inhibitor | 0.872 0.001 CID_5488307 0.9 0.001 CID_15372481 | CID_15372481 | |
| 0.524 | 0.004 | 0.524 | Estrogen receptor beta antagonist | 0.115 0.038 CID_5488307 0.131 0.023 CID_15372481 | ||
| 0.522 | 0.005 | 0.522 | MAO B inhibitor | |||
| 0.523 | 0.009 | 0.523 | RNA-directed DNA polymerase inhibitor | 0.483 0.012 CID_5488307 0.48 0.012 CID_15372481 | ||
| 0.511 | 0.004 | 0.511 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.442 0.005 CID_5488307 0.459 0.005 CID_15372481 | ||
| 0.51 | 0.005 | 0.528 | Lipid peroxidase inhibitor | 0.524 0.005 CID_5488307 0.528 0.005 CID_15372481 | CID_15372481 | |
| 0.498 | 0.002 | 0.498 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.153 0.018 CID_5488307 0.162 0.015 CID_15372481 | ||
| 0.499 | 0.003 | 0.499 | Estrogen receptor alpha antagonist | 0.08 0.049 CID_5488307 0.086 0.041 CID_15372481 | ||
| 0.497 | 0.004 | 0.497 | Estrogen antagonist | 0.157 0.021 CID_5488307 0.194 0.014 CID_15372481 | ||
| 0.495 | 0.005 | 0.495 | Acetylcholinesterase inhibitor | 0.17 0.044 CID_5488307 0.164 0.047 CID_15372481 | ||
| 0.493 | 0.005 | 0.493 | Chelator | 0.222 0.021 CID_5488307 0.237 0.018 CID_15372481 | ||
| 0.5 | 0.014 | 0.542 | DNA damaging | 0.542 0.011 CID_5488307 0.528 0.012 CID_15372481 | CID_5488307 | |
| 0.492 | 0.017 | 0.723 | Vasodilator, coronary | 0.723 0.004 CID_5488307 0.716 0.004 CID_15372481 | CID_5488307 | |
| 0.479 | 0.005 | 0.479 | Aldehyde dehydrogenase inhibitor | 0.409 0.005 CID_5488307 0.444 0.005 CID_15372481 | ||
| 0.473 | 0.008 | 0.473 | Dual specificity phosphatase inhibitor | 0.156 0.087 CID_5488307 0.145 0.1 CID_15372481 | ||
| 0.495 | 0.03 | 0.495 | Calcium channel L-type activator | 0.24 0.217 CID_5488307 0.288 0.168 CID_15372481 | ||
| 0.466 | 0.004 | 0.466 | Carbonic anhydrase VI inhibitor | 0.268 0.008 CID_5488307 0.299 0.006 CID_15372481 | ||
| 0.502 | 0.041 | 0.502 | Prostaglandin dehydrogenase inhibitor | |||
| 0.468 | 0.009 | 0.671 | Hepatoprotectant | 0.666 0.004 CID_5488307 0.671 0.004 CID_15372481 | CID_15372481 | |
| 0.465 | 0.006 | 0.465 | 5 Hydroxytryptamine uptake stimulant | 0.214 0.126 CID_5488307 | ||
| 0.472 | 0.014 | 0.539 | Vasodilator | 0.521 0.01 CID_5488307 0.539 0.009 CID_15372481 | CID_15372481 | |
| 0.455 | 0.005 | 0.455 | 5-Lipoxygenase inhibitor | 0.086 0.075 CID_5488307 0.083 0.077 CID_15372481 | ||
| 0.458 | 0.009 | 0.458 | Tubulin antagonist | 0.142 0.062 CID_5488307 0.132 0.07 CID_15372481 | ||
| 0.448 | 0.004 | 0.448 | Topoisomerase II alpha inhibitor | 0.412 0.005 CID_5488307 0.416 0.004 CID_15372481 | ||
| 0.447 | 0.003 | 0.447 | Histidine decarboxylase inhibitor | 0.092 0.035 CID_5488307 0.103 0.031 CID_15372481 | ||
| 0.446 | 0.003 | 0.454 | Nitric-oxide synthase stimulant | 0.448 0.003 CID_5488307 0.454 0.003 CID_15372481 | CID_15372481 | |
| 0.487 | 0.044 | 0.739 | Antibacterial | 0.727 0.007 CID_5488307 0.739 0.006 CID_15372481 | CID_15372481 | |
| 0.44 | 0.01 | 0.44 | Dual specificity phosphatase 3 inhibitor | 0.145 0.101 CID_5488307 0.131 0.115 CID_15372481 | ||
| 0.452 | 0.027 | 0.452 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.444 | 0.02 | 0.685 | Tumour necrosis factor alpha release inhibitor | 0.586 0.008 CID_5488307 0.685 0.005 CID_15372481 | CID_15372481 | |
| 0.426 | 0.004 | 0.426 | M18 aspartyl aminopeptidase inhibitor | 0.143 0.055 CID_5488307 0.187 0.038 CID_15372481 | ||
| 0.419 | 0.002 | 0.438 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.438 0.002 CID_5488307 0.333 0.003 CID_15372481 | CID_5488307 | |
| 0.417 | 0.004 | 0.417 | Carbonic anhydrase XV inhibitor | 0.099 0.069 CID_5488307 0.107 0.059 CID_15372481 | ||
| 0.418 | 0.014 | 0.638 | Cyclic AMP phosphodiesterase inhibitor | 0.566 0.005 CID_5488307 0.638 0.004 CID_15372481 | CID_15372481 | |
| 0.406 | 0.009 | 0.406 | Cholinergic | |||
| 0.432 | 0.04 | 0.432 | 5 Hydroxytryptamine release stimulant | 0.258 0.085 CID_5488307 0.275 0.078 CID_15372481 | ||
| 0.399 | 0.009 | 0.399 | Protein-tyrosine phosphatase inhibitor | 0.307 0.018 CID_5488307 0.3 0.019 CID_15372481 | ||
| 0.412 | 0.023 | 0.412 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.391 | 0.004 | 0.391 | Aldose reductase inhibitor | 0.299 0.004 CID_5488307 0.315 0.004 CID_15372481 | ||
| 0.386 | 0.004 | 0.553 | Carbonic anhydrase XIII inhibitor | 0.411 0.004 CID_5488307 0.553 0.003 CID_15372481 | CID_15372481 | |
| 0.383 | 0.003 | 0.383 | GABA C receptor antagonist | |||
| 0.383 | 0.006 | 0.468 | Neurotrophic factor enhancer | 0.415 0.005 CID_5488307 0.468 0.004 CID_15372481 | CID_15372481 | |
| 0.385 | 0.009 | 0.541 | Protein kinase stimulant | 0.532 0.004 CID_5488307 0.541 0.003 CID_15372481 | CID_15372481 | |
| 0.377 | 0.003 | 0.377 | Xanthine dehydrogenase inhibitor | 0.206 0.004 CID_5488307 0.204 0.004 CID_15372481 | ||
| 0.378 | 0.004 | 0.378 | Estrogen agonist | 0.184 0.009 CID_5488307 0.234 0.007 CID_15372481 | ||
| 0.379 | 0.006 | 0.411 | Alkaline phosphatase inhibitor | 0.411 0.005 CID_5488307 0.402 0.005 CID_15372481 | CID_5488307 | |
| 0.373 | 0.003 | 0.373 | GABA C receptor rho-1 antagonist | 0.108 0.053 CID_5488307 0.111 0.048 CID_15372481 | ||
| 0.376 | 0.009 | 0.376 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.43 | 0.075 | 0.828 | Cyclophilin D inhibitor | 0.828 0.005 CID_5488307 0.81 0.006 CID_15372481 | CID_5488307 | |
| 0.359 | 0.014 | 0.359 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.343 | 0.002 | 0.343 | DOPA decarboxylase inhibitor | 0.151 0.021 CID_5488307 0.144 0.025 CID_15372481 | ||
| 0.371 | 0.032 | 0.371 | Dyrk kinase inhibitor | |||
| 0.35 | 0.015 | 0.35 | Mcl-1 antagonist | 0.132 0.109 CID_5488307 0.127 0.116 CID_15372481 | ||
| 0.337 | 0.003 | 0.337 | Multidrug resistance-associated protein 1 inhibitor | 0.274 0.004 CID_5488307 0.274 0.004 CID_15372481 | ||
| 0.363 | 0.029 | 0.363 | Transcription factor STAT inhibitor | |||
| 0.336 | 0.005 | 0.336 | Uric acid excretion stimulant | 0.302 0.005 CID_5488307 0.29 0.005 CID_15372481 | ||
| 0.361 | 0.03 | 0.82 | Angiogenesis stimulant | 0.82 0.004 CID_5488307 0.819 0.004 CID_15372481 | CID_5488307 | |
| 0.332 | 0.009 | 0.332 | Protein-tyrosine phosphatase 1B inhibitor | 0.273 0.013 CID_5488307 0.267 0.014 CID_15372481 | ||
| 0.327 | 0.005 | 0.327 | HIV-1 integrase (3'-Processing) inhibitor | 0.175 0.011 CID_5488307 0.169 0.012 CID_15372481 | ||
| 0.342 | 0.022 | 0.502 | Platelet adhesion inhibitor | 0.502 0.005 CID_5488307 0.498 0.005 CID_15372481 | CID_5488307 | |
| 0.324 | 0.003 | 0.324 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.322 | 0.004 | 0.322 | Macrophage migration inhibitory factor inhibitor | 0.072 0.064 CID_5488307 | ||
| 0.354 | 0.038 | 0.354 | Interleukin antagonist | 0.172 0.102 CID_5488307 0.186 0.092 CID_15372481 | ||
| 0.315 | 0.005 | 0.315 | Alcohol dehydrogenase inhibitor | 0.268 0.006 CID_5488307 0.289 0.005 CID_15372481 | ||
| 0.317 | 0.009 | 0.373 | Topoisomerase I inhibitor | 0.37 0.007 CID_5488307 0.373 0.006 CID_15372481 | CID_15372481 | |
| 0.326 | 0.018 | 0.537 | DNA methyltransferase I inhibitor | 0.453 0.005 CID_5488307 0.537 0.004 CID_15372481 | CID_15372481 | |
| 0.313 | 0.01 | 0.313 | Protein kinase (CK2) alpha inhibitor | |||
| 0.312 | 0.009 | 0.312 | Butyrylcholinesterase inhibitor | |||
| 0.325 | 0.023 | 0.626 | Non-steroidal antiinflammatory agent | 0.593 0.004 CID_5488307 0.626 0.004 CID_15372481 | CID_15372481 | |
| 0.353 | 0.061 | 0.353 | Streptokinase A inhibitor | |||
| 0.296 | 0.005 | 0.296 | HIV-1 integrase (Strand Transfer) inhibitor | 0.163 0.012 CID_5488307 0.153 0.013 CID_15372481 | ||
| 0.295 | 0.005 | 0.295 | Aromatase inhibitor | |||
| 0.294 | 0.004 | 0.294 | Cyclin B3 inhibitor | 0.059 0.058 CID_5488307 0.062 0.054 CID_15372481 | ||
| 0.33 | 0.042 | 0.33 | Insulysin inhibitor | |||
| 0.298 | 0.01 | 0.298 | Heat shock protein 90 antagonist | 0.129 0.099 CID_5488307 0.133 0.094 CID_15372481 | ||
| 0.29 | 0.004 | 0.29 | Alpha tubulin antagonist | 0.048 0.043 CID_5488307 0.049 0.043 CID_15372481 | ||
| 0.299 | 0.014 | 0.299 | Heat shock protein 90 alpha antagonist | |||
| 0.288 | 0.004 | 0.288 | Histone deacetylase SIRT1 stimulant | 0.249 0.005 CID_5488307 0.252 0.005 CID_15372481 | ||
| 0.288 | 0.004 | 0.288 | Histone deacetylase stimulant | 0.249 0.005 CID_5488307 0.252 0.005 CID_15372481 | ||
| 0.287 | 0.003 | 0.287 | Fatty acid synthase inhibitor | 0.167 0.004 CID_5488307 0.176 0.004 CID_15372481 | ||
| 0.3 | 0.018 | 0.3 | Tumour necrosis factor antagonist | 0.14 0.113 CID_15372481 | ||
| 0.287 | 0.007 | 0.287 | Telomerase inhibitor | 0.089 0.039 CID_5488307 0.079 0.045 CID_15372481 | ||
| 0.293 | 0.019 | 0.293 | Amyloid beta precursor protein antagonist | |||
| 0.298 | 0.028 | 0.517 | DNA methylase inhibitor | 0.444 0.008 CID_5488307 0.517 0.005 CID_15372481 | CID_15372481 | |
| 0.272 | 0.002 | 0.272 | D-Ala-D-Ala ligase inhibitor | 0.088 0.049 CID_5488307 0.089 0.046 CID_15372481 | ||
| 0.282 | 0.014 | 0.282 | Succinate dehydrogenase inhibitor | 0.154 0.106 CID_5488307 | ||
| 0.281 | 0.017 | 0.281 | Cyclooxygenase 1 inhibitor | 0.184 0.041 CID_5488307 0.178 0.044 CID_15372481 | ||
| 0.264 | 0.004 | 0.264 | Estrogen receptor beta agonist | 0.118 0.009 CID_5488307 0.152 0.007 CID_15372481 | ||
| 0.278 | 0.021 | 0.278 | Cyclooxygenase inhibitor | 0.186 0.047 CID_5488307 0.178 0.052 CID_15372481 | ||
| 0.376 | 0.126 | 0.376 | DNA directed DNA polymerase inhibitor | |||
| 0.273 | 0.024 | 0.472 | Interferon gamma antagonist | 0.452 0.008 CID_5488307 0.472 0.007 CID_15372481 | CID_15372481 | |
| 0.258 | 0.009 | 0.639 | Mediator release inhibitor | 0.639 0.003 CID_5488307 0.637 0.003 CID_15372481 | CID_5488307 | |
| 0.285 | 0.041 | 0.285 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.373 | 0.13 | 0.373 | DNA polymerase beta inhibitor | |||
| 0.249 | 0.006 | 0.249 | CF transmembrane conductance regulator agonist | 0.193 0.026 CID_5488307 0.179 0.038 CID_15372481 | ||
| 0.28 | 0.042 | 0.28 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.285 | 0.048 | 0.285 | Antimitotic | 0.155 0.116 CID_5488307 0.137 0.136 CID_15372481 | ||
| 0.241 | 0.004 | 0.241 | Carbonic anhydrase VII inhibitor | 0.12 0.008 CID_5488307 0.165 0.005 CID_15372481 | ||
| 0.234 | 0.004 | 0.234 | Myeloperoxidase inhibitor | |||
| 0.238 | 0.008 | 0.238 | Protein kinase C zeta inhibitor | |||
| 0.258 | 0.03 | 0.258 | Insulin sensitizer | 0.251 0.034 CID_5488307 0.227 0.05 CID_15372481 | ||
| 0.232 | 0.006 | 0.232 | Beta tubulin antagonist | |||
| 0.229 | 0.006 | 0.229 | Keratolytic | |||
| 0.236 | 0.013 | 0.236 | Protein kinase (CK2) inhibitor | |||
| 0.227 | 0.005 | 0.227 | CDC25A inhibitor | 0.11 0.023 CID_5488307 0.107 0.024 CID_15372481 | ||
| 0.226 | 0.004 | 0.248 | Heat shock protein 70 antagonist | 0.248 0.004 CID_5488307 0.244 0.004 CID_15372481 | CID_5488307 | |
| 0.227 | 0.006 | 0.227 | Papain-like protease (SARS coronavirus) inhibitor | 0.121 0.078 CID_5488307 0.13 0.06 CID_15372481 | ||
| 0.267 | 0.047 | 0.267 | MAP kinase kinase 2 inhibitor | |||
| 0.235 | 0.018 | 0.458 | Alkylator | 0.458 0.005 CID_5488307 0.443 0.006 CID_15372481 | CID_5488307 | |
| 0.241 | 0.027 | 0.241 | Bone formation stimulant | 0.168 0.047 CID_5488307 0.161 0.051 CID_15372481 | ||
| 0.217 | 0.003 | 0.217 | GABA B receptor antagonist | |||
| 0.217 | 0.004 | 0.217 | Estrogen receptor alpha agonist | 0.033 0.024 CID_5488307 0.056 0.016 CID_15372481 | ||
| 0.235 | 0.023 | 0.235 | Cyclooxygenase 2 inhibitor | 0.155 0.05 CID_5488307 0.149 0.054 CID_15372481 | ||
| 0.224 | 0.012 | 0.589 | Cyclooxygenase 3 inhibitor | 0.589 0.002 CID_5488307 0.56 0.003 CID_15372481 | CID_5488307 | |
| 0.297 | 0.09 | 0.721 | Antithrombotic | 0.716 0.007 CID_5488307 0.721 0.007 CID_15372481 | CID_15372481 | |
| 0.215 | 0.018 | 0.215 | Toll-Like receptor 2 antagonist | |||
| 0.219 | 0.023 | 0.219 | DNA polymerase I inhibitor | 0.216 0.024 CID_5488307 0.218 0.023 CID_15372481 | ||
| 0.219 | 0.023 | 0.219 | Cholesterol synthesis inhibitor | 0.161 0.039 CID_5488307 0.149 0.045 CID_15372481 | ||
| 0.208 | 0.013 | 0.208 | Androgen antagonist | |||
| 0.197 | 0.003 | 0.197 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.202 | 0.01 | 0.202 | Urease inhibitor | |||
| 0.197 | 0.007 | 0.197 | Transcription factor STAT6 inhibitor | |||
| 0.217 | 0.027 | 0.561 | Hemostatic | 0.561 0.004 CID_5488307 0.543 0.004 CID_15372481 | CID_5488307 | |
| 0.2 | 0.011 | 0.578 | AMP-activated protein kinase stimulant | 0.578 0.003 CID_5488307 0.546 0.003 CID_15372481 | CID_5488307 | |
| 0.217 | 0.028 | 0.388 | Insulin secretagoues | 0.388 0.007 CID_5488307 0.359 0.008 CID_15372481 | CID_5488307 | |
| 0.21 | 0.025 | 0.227 | Mannose-6-phosphate isomerase inhibitor | 0.227 0.018 CID_5488307 0.207 0.027 CID_15372481 | CID_5488307 | |
| 0.191 | 0.008 | 0.191 | Carbonic anhydrase V inhibitor | |||
| 0.192 | 0.01 | 0.444 | DNA repair enzyme inhibitor | 0.444 0.003 CID_5488307 0.394 0.003 CID_15372481 | CID_5488307 | |
| 0.207 | 0.027 | 0.207 | Arachidonic acid antagonist | 0.138 0.102 CID_5488307 | ||
| 0.201 | 0.022 | 0.201 | Antibacterial (Helicobacter pylori) | 0.122 0.078 CID_5488307 0.132 0.065 CID_15372481 | ||
| 0.268 | 0.089 | 0.549 | Immunostimulant | 0.549 0.023 CID_5488307 0.541 0.024 CID_15372481 | CID_5488307 | |
| 0.181 | 0.004 | 0.181 | Topoisomerase II beta inhibitor | 0.147 0.005 CID_5488307 0.145 0.005 CID_15372481 | ||
| 0.186 | 0.01 | 0.193 | Thioredoxin inhibitor | 0.193 0.009 CID_5488307 0.185 0.01 CID_15372481 | CID_5488307 | |
| 0.183 | 0.006 | 0.183 | Carbonic anhydrase VB inhibitor | |||
| 0.191 | 0.015 | 0.281 | Photosensitizer | 0.281 0.005 CID_5488307 0.258 0.005 CID_15372481 | CID_5488307 | |
| 0.186 | 0.011 | 0.186 | Prolactin inhibitor | |||
| 0.204 | 0.033 | 0.204 | Neurotensin receptor agonist | |||
| 0.251 | 0.082 | 0.251 | Transcription factor STAT3 inhibitor | |||
| 0.201 | 0.034 | 0.371 | Hexokinase inhibitor | 0.371 0.005 CID_5488307 0.337 0.007 CID_15372481 | CID_5488307 | |
| 0.187 | 0.02 | 0.187 | Adenylate cyclase stimulant | 0.135 0.09 CID_5488307 0.135 0.092 CID_15372481 | ||
| 0.19 | 0.025 | 0.19 | Farnesoid X receptor antagonist | |||
| 0.175 | 0.012 | 0.175 | Electron transport complex I inhibitor | 0.11 0.062 CID_5488307 0.109 0.063 CID_15372481 | ||
| 0.17 | 0.007 | 0.17 | Carbonic anhydrase VA inhibitor | |||
| 0.2 | 0.037 | 0.337 | ATPase inhibitor | 0.337 0.004 CID_5488307 0.327 0.005 CID_15372481 | CID_5488307 | |
| 0.17 | 0.01 | 0.17 | Glutamate decarboxylase inhibitor | |||
| 0.226 | 0.067 | 0.231 | Psychostimulant | 0.231 0.066 CID_5488307 0.221 0.07 CID_15372481 | CID_5488307 | |
| 0.164 | 0.006 | 0.19 | Neuraminidase (influenza) inhibitor | 0.19 0.005 CID_5488307 0.186 0.005 CID_15372481 | CID_5488307 | |
| 0.163 | 0.005 | 0.163 | CD45 antagonist | |||
| 0.19 | 0.034 | 0.393 | Cell wall synthesis inhibitor | 0.393 0.006 CID_5488307 0.373 0.007 CID_15372481 | CID_5488307 | |
| 0.197 | 0.043 | 0.288 | Interleukin 6 antagonist | 0.288 0.016 CID_5488307 0.247 0.024 CID_15372481 | CID_5488307 | |
| 0.161 | 0.007 | 0.161 | HIV-1 integrase inhibitor | 0.092 0.03 CID_5488307 0.092 0.03 CID_15372481 | ||
| 0.212 | 0.061 | 0.212 | I kappa B kinase epsilon inhibitor | |||
| 0.195 | 0.047 | 0.195 | Phospholipase C inhibitor | 0.172 0.07 CID_5488307 0.157 0.092 CID_15372481 | ||
| 0.156 | 0.009 | 0.156 | Ornithine decarboxylase inhibitor | 0.128 0.02 CID_5488307 0.119 0.027 CID_15372481 | ||
| 0.167 | 0.021 | 0.167 | TRPA1 agonist | 0.105 0.08 CID_5488307 0.112 0.069 CID_15372481 | ||
| 0.269 | 0.125 | 0.269 | Calcium channel activator | |||
| 0.163 | 0.021 | 0.163 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.149 | 0.009 | 0.149 | Thioredoxin reductase inhibitor | 0.089 0.043 CID_5488307 0.089 0.042 CID_15372481 | ||
| 0.226 | 0.087 | 0.38 | DNA synthesis inhibitor | 0.38 0.024 CID_5488307 0.376 0.025 CID_15372481 | CID_5488307 | |
| 0.166 | 0.027 | 0.314 | Antineoplastic antibiotic | 0.314 0.009 CID_5488307 0.313 0.009 CID_15372481 | CID_5488307 | |
| 0.257 | 0.12 | 0.257 | Sodium/bile acid cotransporter inhibitor | 0.205 0.181 CID_5488307 | ||
| 0.187 | 0.05 | 0.187 | Phospholipase A2 inhibitor | 0.153 0.072 CID_5488307 0.144 0.081 CID_15372481 | ||
| 0.141 | 0.004 | 0.141 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.142 | 0.007 | 0.142 | CDC25B inhibitor | 0.06 0.05 CID_5488307 0.059 0.052 CID_15372481 | ||
| 0.137 | 0.003 | 0.137 | Dopamine D5 agonist | |||
| 0.175 | 0.043 | 0.281 | Alpha-N-acetylglucosaminidase inhibitor | 0.281 0.018 CID_5488307 0.248 0.023 CID_15372481 | CID_5488307 | |
| 0.254 | 0.122 | 0.519 | Cholesterol antagonist | 0.519 0.03 CID_5488307 0.46 0.039 CID_15372481 | CID_5488307 | |
| 0.159 | 0.028 | 0.19 | Mucolytic | 0.168 0.023 CID_5488307 0.19 0.016 CID_15372481 | CID_15372481 | |
| 0.138 | 0.007 | 0.155 | Neuraminidase inhibitor | 0.155 0.005 CID_5488307 0.152 0.005 CID_15372481 | CID_5488307 | |
| 0.142 | 0.011 | 0.142 | Lipase inhibitor | 0.102 0.026 CID_5488307 0.092 0.032 CID_15372481 | ||
| 0.251 | 0.122 | 0.382 | Angiogenesis inhibitor | 0.382 0.059 CID_5488307 0.309 0.088 CID_15372481 | CID_5488307 | |
| 0.133 | 0.003 | 0.133 | Transcription factor RelA inhibitor | |||
| 0.147 | 0.019 | 0.147 | Anabolic | |||
| 0.13 | 0.003 | 0.13 | ATP citrate lysase inhibitor | 0.037 0.015 CID_5488307 0.034 0.018 CID_15372481 | ||
| 0.132 | 0.006 | 0.132 | Aryl hydrocarbon receptor antagonist | |||
| 0.137 | 0.015 | 0.137 | Interleukin 5 antagonist | 0.12 0.024 CID_5488307 0.119 0.025 CID_15372481 | ||
| 0.154 | 0.034 | 0.513 | Expectorant | 0.455 0.004 CID_5488307 0.513 0.004 CID_15372481 | CID_15372481 | |
| 0.125 | 0.005 | 0.125 | DNA-dependent protein kinase inhibitor | |||
| 0.124 | 0.004 | 0.124 | Catechol O-methyltransferase inhibitor | |||
| 0.246 | 0.126 | 0.246 | Thyroid hormone antagonist | |||
| 0.177 | 0.058 | 0.177 | Death-associated protein kinase 2 inhibitor | |||
| 0.126 | 0.009 | 0.126 | Maillard reaction inhibitor | 0.09 0.021 CID_5488307 0.084 0.023 CID_15372481 | ||
| 0.128 | 0.013 | 0.128 | Alcohol oxidase inhibitor | |||
| 0.122 | 0.007 | 0.122 | Cyclin B1 inhibitor | |||
| 0.245 | 0.13 | 0.262 | Vasodilator, peripheral | 0.219 0.155 CID_5488307 0.262 0.119 CID_15372481 | CID_15372481 | |
| 0.12 | 0.006 | 0.12 | Cyclin B2 inhibitor | |||
| 0.151 | 0.04 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.147 0.051 CID_5488307 0.142 0.064 CID_15372481 | ||
| 0.139 | 0.029 | 0.139 | Sphingomyelinase inhibitor | 0.115 0.045 CID_5488307 0.115 0.045 CID_15372481 | ||
| 0.131 | 0.021 | 0.156 | Interleukin 12 antagonist | 0.145 0.014 CID_5488307 0.156 0.011 CID_15372481 | CID_15372481 | |
| 0.14 | 0.033 | 0.317 | UDP-glucose 4-epimerase inhibitor | 0.317 0.009 CID_5488307 0.28 0.011 CID_15372481 | CID_5488307 | |
| 0.115 | 0.008 | 0.233 | Carbonic anhydrase XIV inhibitor | 0.223 0.004 CID_5488307 0.233 0.004 CID_15372481 | CID_15372481 | |
| 0.139 | 0.032 | 0.139 | Potassium channel (Ca-activated) activator | |||
| 0.119 | 0.017 | 0.119 | Leukotriene synthesis inhibitor | |||
| 0.188 | 0.088 | 0.188 | Histone acetyltransferase inhibitor | |||
| 0.107 | 0.009 | 0.107 | Cyclin B inhibitor | |||
| 0.159 | 0.06 | 0.159 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.143 | 0.045 | 0.167 | Beta amyloid protein antagonist | 0.167 0.03 CID_5488307 0.156 0.037 CID_15372481 | CID_5488307 | |
| 0.247 | 0.15 | 0.518 | Immunosuppressant | 0.518 0.028 CID_5488307 0.509 0.03 CID_15372481 | CID_5488307 | |
| 0.113 | 0.017 | 0.113 | Leukotriene antagonist | 0.108 0.019 CID_5488307 0.097 0.023 CID_15372481 | ||
| 0.228 | 0.132 | 0.228 | Thyroid hormone beta antagonist | |||
| 0.145 | 0.05 | 0.145 | Proteasome inhibitor | |||
| 0.097 | 0.003 | 0.097 | Estrogen-related receptor beta antagonist | 0.031 0.025 CID_5488307 0.037 0.014 CID_15372481 | ||
| 0.117 | 0.024 | 0.117 | Glutathione S-transferase inhibitor | |||
| 0.113 | 0.021 | 0.113 | Dopamine D1 antagonist | |||
| 0.095 | 0.004 | 0.095 | Protein kinase (CK2) beta inhibitor | |||
| 0.12 | 0.03 | 0.12 | Aminoacyl-tRNA synthetase inhibitor | 0.095 0.051 CID_5488307 0.091 0.057 CID_15372481 | ||
| 0.112 | 0.023 | 0.112 | Dopamine agonist | |||
| 0.147 | 0.06 | 0.147 | Interleukin 1 antagonist | |||
| 0.117 | 0.03 | 0.213 | NADH dehydrogenase inhibitor | 0.213 0.009 CID_5488307 0.191 0.011 CID_15372481 | CID_5488307 | |
| 0.097 | 0.012 | 0.097 | Heat shock protein 90 beta antagonist | |||
| 0.098 | 0.012 | 0.098 | Glutamate (mGluR7) antagonist | |||
| 0.135 | 0.05 | 0.2 | DNA intercalator | 0.2 0.026 CID_5488307 0.192 0.028 CID_15372481 | CID_5488307 | |
| 0.138 | 0.053 | 0.138 | Adenylate cyclase inhibitor | |||
| 0.098 | 0.014 | 0.098 | MAP kinase kinase 7 inhibitor | |||
| 0.088 | 0.005 | 0.149 | Arginase inhibitor | 0.147 0.002 CID_5488307 0.149 0.002 CID_15372481 | CID_15372481 | |
| 0.127 | 0.045 | 0.127 | GABA C receptor agonist | |||
| 0.107 | 0.026 | 0.107 | mTOR complex 2 inhibitor | |||
| 0.157 | 0.077 | 0.384 | Thrombolytic | 0.37 0.014 CID_5488307 0.384 0.013 CID_15372481 | CID_15372481 | |
| 0.107 | 0.027 | 0.107 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.092 | 0.013 | 0.092 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.111 | 0.032 | 0.111 | Phosphodiesterase 4D inhibitor | |||
| 0.109 | 0.032 | 0.109 | CYP2A6 inhibitor | |||
| 0.094 | 0.016 | 0.094 | Protease activated receptor antagonist | |||
| 0.127 | 0.053 | 0.127 | Interleukin 8 antagonist | |||
| 0.082 | 0.008 | 0.082 | Ryanodine receptor antagonist | |||
| 0.087 | 0.014 | 0.087 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.099 | 0.026 | 0.099 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.08 | 0.007 | 0.08 | Cholesterol esterase inhibitor | 0.043 0.042 CID_5488307 | ||
| 0.099 | 0.026 | 0.099 | Estrogen-related receptor beta agonist | |||
| 0.102 | 0.03 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.123 0.014 CID_5488307 0.124 0.014 CID_15372481 | CID_15372481 | |
| 0.093 | 0.021 | 0.171 | Carbonic anhydrase XII inhibitor | 0.171 0.01 CID_5488307 0.17 0.01 CID_15372481 | CID_5488307 | |
| 0.117 | 0.046 | 0.179 | Toll-Like receptor 4 antagonist | 0.179 0.01 CID_5488307 0.178 0.01 CID_15372481 | CID_5488307 | |
| 0.108 | 0.039 | 0.166 | Phosphodiesterase 6D inhibitor | 0.155 0.008 CID_5488307 0.166 0.007 CID_15372481 | CID_15372481 | |
| 0.084 | 0.015 | 0.084 | Cyclin D1 inhibitor | |||
| 0.085 | 0.018 | 0.085 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.072 | 0.007 | 0.083 | Neuraminidase (Influenza A) inhibitor | 0.083 0.005 CID_5488307 0.081 0.005 CID_15372481 | CID_5488307 | |
| 0.101 | 0.036 | 0.101 | Porphobilinogen synthase inhibitor | |||
| 0.079 | 0.015 | 0.132 | Leukotriene B4 antagonist | 0.132 0.006 CID_5488307 0.125 0.007 CID_15372481 | CID_5488307 | |
| 0.083 | 0.021 | 0.083 | Beta 3 adrenoreceptor antagonist | |||
| 0.068 | 0.007 | 0.068 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.105 | 0.043 | 0.188 | Triose-phosphate isomerase inhibitor | 0.188 0.012 CID_5488307 0.166 0.016 CID_15372481 | CID_5488307 | |
| 0.121 | 0.06 | 0.156 | Microtubule formation inhibitor | 0.156 0.034 CID_5488307 0.145 0.04 CID_15372481 | CID_5488307 | |
| 0.129 | 0.069 | 0.129 | Vanilloid 1 agonist | 0.12 0.088 CID_5488307 0.118 0.092 CID_15372481 | ||
| 0.077 | 0.018 | 0.077 | Sphingosine kinase inhibitor | |||
| 0.102 | 0.044 | 0.102 | Bile acid receptor antagonist | |||
| 0.073 | 0.015 | 0.073 | Dihydroorotate oxidase inhibitor | |||
| 0.071 | 0.015 | 0.123 | Glucose-6-phosphate translocase inhibitor | 0.119 0.004 CID_5488307 0.123 0.004 CID_15372481 | CID_15372481 | |
| 0.079 | 0.024 | 0.079 | Androgen agonist | |||
| 0.102 | 0.048 | 0.102 | ABCA1 expression enhancer | |||
| 0.132 | 0.078 | 0.132 | Neurotrophic factor | 0.122 0.092 CID_5488307 0.116 0.102 CID_15372481 | ||
| 0.108 | 0.054 | 0.108 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.165 | 0.112 | 0.165 | Growth factor agonist | |||
| 0.138 | 0.087 | 0.301 | Diuretic | 0.301 0.022 CID_5488307 0.285 0.025 CID_15372481 | CID_5488307 | |
| 0.089 | 0.039 | 0.115 | T cell inhibitor | 0.115 0.016 CID_5488307 0.103 0.022 CID_15372481 | CID_5488307 | |
| 0.066 | 0.016 | 0.066 | Squalene epoxidase inhibitor | |||
| 0.084 | 0.035 | 0.084 | MAP3K7 inhibitor | |||
| 0.066 | 0.018 | 0.066 | Leukotriene C antagonist | |||
| 0.083 | 0.036 | 0.096 | Phosphodiesterase VI inhibitor | 0.09 0.028 CID_5488307 0.096 0.023 CID_15372481 | CID_15372481 | |
| 0.086 | 0.04 | 0.086 | Cathepsin G inhibitor | |||
| 0.064 | 0.017 | 0.064 | CXC chemokine 1 receptor antagonist | |||
| 0.127 | 0.083 | 0.127 | Cytokine production inhibitor | |||
| 0.058 | 0.016 | 0.058 | Purinergic P2X4 antagonist | |||
| 0.068 | 0.027 | 0.068 | GABA receptor antagonist | |||
| 0.079 | 0.039 | 0.079 | CDK1/cyclin B1 inhibitor | |||
| 0.047 | 0.008 | 0.047 | Estrone sulfatase inhibitor | |||
| 0.077 | 0.038 | 0.077 | Potassium channel large-conductance Ca-activated activator | |||
| 0.146 | 0.108 | 0.146 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.088 | 0.05 | 0.088 | Inducible nitric-oxide synthase inhibitor | |||
| 0.079 | 0.044 | 0.079 | GABA B receptor agonist | |||
| 0.065 | 0.031 | 0.065 | Protein kinase C eta inhibitor | |||
| 0.056 | 0.022 | 0.056 | Dopamine D5 antagonist | |||
| 0.086 | 0.053 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.076 | 0.043 | 0.162 | Phosphofructokinase-1 inhibitor | 0.162 0.016 CID_5488307 0.145 0.019 CID_15372481 | CID_5488307 | |
| 0.088 | 0.055 | 0.088 | NMDA receptor antagonist | |||
| 0.065 | 0.033 | 0.065 | Heme oxygenase stimulant | |||
| 0.055 | 0.023 | 0.055 | Dopamine D2 agonist | 0.041 0.033 CID_15372481 | ||
| 0.049 | 0.018 | 0.049 | DNA gyrase subunit A inhibitor | |||
| 0.169 | 0.14 | 0.169 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.069 | 0.04 | 0.069 | Beta adrenoreceptor antagonist | |||
| 0.145 | 0.117 | 0.145 | Catenin beta inhibitor | |||
| 0.038 | 0.01 | 0.038 | Dopamine autoreceptor agonist | |||
| 0.096 | 0.069 | 0.096 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.058 | 0.031 | 0.058 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.064 | 0.038 | 0.064 | Purinergic P2X1 antagonist | |||
| 0.096 | 0.07 | 0.096 | Alpha 2c adrenoreceptor antagonist | |||
| 0.068 | 0.043 | 0.068 | Glutamate (mGluR6) antagonist | |||
| 0.067 | 0.041 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.032 | 0.008 | 0.041 | Dopamine D1 agonist | 0.041 0.005 CID_5488307 0.037 0.006 CID_15372481 | CID_5488307 | |
| 0.189 | 0.165 | 0.189 | Gastrin inhibitor | |||
| 0.119 | 0.096 | 0.119 | CDC-like kinase 1 inhibitor | |||
| 0.064 | 0.041 | 0.089 | Nitric oxide donor | 0.089 0.015 CID_5488307 0.089 0.015 CID_15372481 | CID_15372481 | |
| 0.132 | 0.109 | 0.132 | MAP kinase kinase 4 inhibitor | |||
| 0.048 | 0.026 | 0.048 | Carbonic anhydrase IV inhibitor | |||
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | |||
| 0.093 | 0.072 | 0.093 | Bronchodilator | |||
| 0.127 | 0.106 | 0.127 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.09 | 0.069 | 0.09 | MAP kinase kinase 1 inhibitor | |||
| 0.096 | 0.075 | 0.096 | Adenylate kinase inhibitor | |||
| 0.044 | 0.024 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.05 | 0.03 | 0.067 | Glucose-6-phosphate isomerase inhibitor | 0.067 0.014 CID_5488307 0.063 0.017 CID_15372481 | CID_5488307 | |
| 0.038 | 0.018 | 0.038 | Estrogen-related receptor alpha antagonist | |||
| 0.031 | 0.012 | 0.031 | Thyroid hormone agonist | |||
| 0.063 | 0.044 | 0.064 | Carbonic anhydrase inhibitor | 0.064 0.044 CID_5488307 0.061 0.045 CID_15372481 | CID_5488307 | |
| 0.045 | 0.026 | 0.045 | Cathepsin L2 inhibitor | |||
| 0.08 | 0.061 | 0.08 | Ca(v)3.1 blocker | |||
| 0.041 | 0.024 | 0.041 | Retinoic acid alpha receptor agonist | |||
| 0.048 | 0.031 | 0.048 | Potassium channel Kv1.3 blocker | |||
| 0.167 | 0.152 | 0.395 | Peptidyltransferase inhibitor | 0.395 0.007 CID_5488307 0.393 0.007 CID_15372481 | CID_5488307 | |
| 0.052 | 0.037 | 0.052 | Vanilloid 2 antagonist | |||
| 0.043 | 0.028 | 0.043 | Heme oxygenase inhibitor | |||
| 0.047 | 0.033 | 0.047 | Adenosine deaminase inhibitor | |||
| 0.057 | 0.044 | 0.057 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.041 | 0.028 | 0.041 | Liver X receptor alpha agonist | |||
| 0.117 | 0.105 | 0.117 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.023 | 0.014 | 0.027 | Leukotriene B4 receptor 2 antagonist | 0.027 0.011 CID_5488307 0.026 0.011 CID_15372481 | CID_5488307 | |
| 0.066 | 0.057 | 0.066 | Protein kinase C beta inhibitor | |||
| 0.037 | 0.028 | 0.037 | Glutamate (mGluR8) agonist | |||
| 0.07 | 0.061 | 0.07 | GABA aminotransferase inhibitor | |||
| 0.028 | 0.02 | 0.028 | Leukotriene B4 receptor 1 antagonist | 0.027 0.02 CID_5488307 0.025 0.022 CID_15372481 | ||
| 0.068 | 0.06 | 0.068 | Glutamate dehydrogenase inhibitor | |||
| 0.037 | 0.029 | 0.037 | Retinoid X receptor antagonist | |||
| 0.026 | 0.019 | 0.11 | Sodium/glucose cotransporter 2 inhibitor | 0.11 0.003 CID_5488307 0.106 0.003 CID_15372481 | CID_5488307 | |
| 0.063 | 0.056 | 0.063 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.016 | 0.009 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.117 | 0.111 | 0.117 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.065 | 0.059 | 0.065 | Secretase beta inhibitor | |||
| 0.043 | 0.037 | 0.043 | Adenylate cyclase 1 inhibitor | |||
| 0.025 | 0.02 | 0.098 | Sodium/glucose cotransporter inhibitor | 0.098 0.003 CID_5488307 0.094 0.003 CID_15372481 | CID_5488307 | |
| 0.019 | 0.014 | 0.032 | Antibiotic Anthracycline-like | 0.032 0.003 CID_5488307 0.031 0.003 CID_15372481 | CID_5488307 | |
| 0.161 | 0.157 | 0.298 | Interleukin agonist | 0.298 0.049 CID_5488307 0.274 0.062 CID_15372481 | CID_5488307 | |
| 0.035 | 0.032 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.031 | 0.028 | 0.031 | Progesterone antagonist | |||
| 0.078 | 0.077 | 0.078 | Vanilloid agonist | |||
| 0.09 | 0.089 | 0.09 | 5 Hydroxytryptamine 3A agonist | |||
| 0.061 | 0.06 | 0.061 | Elastase 1 inhibitor | |||
| 0.047 | 0.046 | 0.047 | GABA A receptor antagonist | |||
| 0.038 | 0.037 | 0.038 | Sphingosine kinase 1 inhibitor | |||
| 0.02 | 0.023 | 0.074 | Protein 30S ribosomal subunit inhibitor | 0.074 0.004 CID_5488307 0.071 0.005 CID_15372481 | CID_5488307 | |
| 0.053 | 0.059 | 0.065 | Transcription factor AP-1 inhibitor | 0.065 0.036 CID_5488307 0.065 0.037 CID_15372481 | CID_15372481 | |
| 0.021 | 0.029 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 CID_5488307 0.034 0.006 CID_15372481 | CID_5488307 | |
| 0.052 | 0.06 | 0.07 | Lipocortins synthesis agonist | 0.07 0.022 CID_5488307 0.069 0.023 CID_15372481 | CID_5488307 | |
| 0.013 | 0.025 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_5488307 0.018 0.011 CID_15372481 | CID_5488307 | |
| 0.126 | 0.142 | 0.136 | Anesthetic general | 0.136 0.13 CID_15372481 | CID_15372481 | |
| 0.035 | 0.056 | 0.055 | Carbonic anhydrase IX inhibitor | 0.055 0.039 CID_5488307 0.05 0.042 CID_15372481 | CID_5488307 | |
| 0.073 | 0.097 | 0.089 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.089 0.067 CID_5488307 | CID_5488307 | |
| 0.061 | 0.094 | 0.079 | Interferon agonist | 0.079 0.053 CID_5488307 0.072 0.066 CID_15372481 | CID_5488307 | |
| 0.041 | 0.075 | 0.12 | Heparanase inhibitor | 0.12 0.003 CID_5488307 0.103 0.004 CID_15372481 | CID_5488307 | |
| 0.04 | 0.08 | 0.056 | Factor III inhibitor | 0.054 0.026 CID_5488307 0.056 0.023 CID_15372481 | CID_15372481 | |
| 0.019 | 0.061 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 CID_5488307 0.031 0.014 CID_15372481 | CID_15372481 | |
| 0.025 | 0.07 | 0.08 | Antibiotic Aminoglycoside-like | 0.08 0.004 CID_5488307 0.078 0.005 CID_15372481 | CID_5488307 | |
| 0.035 | 0.088 | 0.38 | Selectin antagonist | 0.38 0.004 CID_5488307 0.362 0.004 CID_15372481 | CID_5488307 | |
| 0.005 | 0.063 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_5488307 0.016 0.014 CID_15372481 | CID_5488307 | |
| 0.055 | 0.113 | 0.095 | Glycine receptor antagonist | 0.095 0.037 CID_5488307 0.092 0.04 CID_15372481 | CID_5488307 | |
| 0.043 | 0.101 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 CID_5488307 0.066 0.019 CID_15372481 | CID_5488307 | |
| 0.122 | 0.182 | 0.346 | Platelet antagonist | 0.346 0.039 CID_5488307 0.344 0.04 CID_15372481 | CID_5488307 | |
| 0.034 | 0.1 | 0.045 | Cytokine production stimulant | 0.045 0.044 CID_5488307 | CID_5488307 | |
| 0.06 | 0.14 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.125 0.016 CID_5488307 0.122 0.018 CID_15372481 | CID_5488307 | |
| 0.061 | 0.143 | 0.156 | Transcription factor NF kappa B stimulant | 0.147 0.016 CID_5488307 0.156 0.015 CID_15372481 | CID_15372481 | |
| 0.029 | 0.115 | 0.067 | Alpha-mannosidase inhibitor | 0.067 0.019 CID_5488307 0.061 0.026 CID_15372481 | CID_5488307 | |
| 0.052 | 0.148 | 0.101 | Falcipain 2 inhibitor | 0.101 0.052 CID_5488307 0.085 0.064 CID_15372481 | CID_5488307 | |
| 0.017 | 0.115 | 0.058 | Phosphorylase inhibitor | 0.058 0.026 CID_5488307 0.039 0.038 CID_15372481 | CID_5488307 | |
| 0.053 | 0.153 | 0.102 | Falcipain inhibitor | 0.102 0.053 CID_5488307 0.086 0.066 CID_15372481 | CID_5488307 | |
| 0.02 | 0.12 | 0.059 | Mannosidase inhibitor | 0.059 0.018 CID_5488307 0.052 0.023 CID_15372481 | CID_5488307 | |
| 0.022 | 0.149 | 0.046 | Microtubule stabilization | 0.046 0.033 CID_5488307 0.045 0.034 CID_15372481 | CID_5488307 | |
| 0.093 | 0.223 | 0.294 | Hypolipemic | 0.294 0.05 CID_5488307 0.267 0.06 CID_15372481 | CID_5488307 | |
| 0.027 | 0.2 | 0.064 | DNA gyrase inhibitor | 0.064 0.043 CID_5488307 0.057 0.053 CID_15372481 | CID_5488307 | |
| 0.017 | 0.206 | 0.105 | Protein 50S ribosomal subunit inhibitor | 0.105 0.012 CID_5488307 0.101 0.013 CID_15372481 | CID_5488307 | |
| 0.097 | 0.31 | 0.145 | CC chemokine 6 receptor antagonist | 0.145 0.03 CID_5488307 0.142 0.035 CID_15372481 | CID_5488307 | |
| 0.132 | 0.349 | 0.404 | Interleukin 2 agonist | 0.404 0.026 CID_5488307 0.395 0.029 CID_15372481 | CID_5488307 | |
| 0.034 | 0.432 | 0.235 | Cell adhesion inhibitor | 0.235 0.017 CID_5488307 0.2 0.025 CID_15372481 | CID_5488307 | |
| 0.012 | 0.426 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 CID_5488307 0.03 0.012 CID_15372481 | CID_15372481 | |
| 0.045 | 0.587 | 0.213 | Toll-Like receptor agonist | 0.213 0.187 CID_15372481 | CID_15372481 | |
| 0.048 | 0.593 | 0.392 | Immunomodulator | 0.392 0.046 CID_5488307 0.356 0.058 CID_15372481 | CID_5488307 | |
| 0.013 | 0.644 | 0.195 | Anticoagulant | 0.195 0.055 CID_5488307 0.194 0.055 CID_15372481 | CID_5488307 | |
| 0.009 | 0.642 | 0.096 | Cell adhesion molecule inhibitor | 0.096 0.038 CID_5488307 0.077 0.057 CID_15372481 | CID_5488307 | |
| 0.012 | 0.741 | 0.065 | Factor IXa inhibitor | 0.065 0.023 CID_5488307 0.051 0.036 CID_15372481 | CID_5488307 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |